Viri in reference:
1. Maras A. et al: Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology, Volume 28, Number 10, 2018, DOI: 10.1089/cap.2018.0020
2. Schroder C. M. et al. Pediatric Prolonged‑Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life. Journal of Autism and Developmental Disorders (2019) 49:3218–3230
3. Dahl RE. Sleep and the Developing Brain. Sleep. 2007;30(9):1079-1080.
4. Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci. 2007 May;64(10):1174-86.
5. Howes OD et al. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol 32:3–29, 2018
6: Yavuz-Kodat E. et al: Disturbances of Continuous Sleep and Circadian Rhythms Account for Behavioral Difficulties in Children with Autism Spectrum Disorder. J Clin Med. 2020 Jun 24;9(6):1978. doi: 10.3390/jcm9061978.
7: Blackmer AB, Feinstein JA. Management of Sleep Disorders in Children with Neurodevelopmental Disorders: A Review. Pharmacotherapy. 2016;36(1):84-98.
8: James E Jan et al: Long-term sleep disturbances in children: a cause of neuronal loss. Eur J Paediatr Neurol. 2010 Sep;14(5):380-90. doi: 10.1016/j.ejpn.2010.05.001. Epub 2010 Jun 2.
SI-AVT-0323-001